98 related articles for article (PubMed ID: 26285537)
21. Transformation of proliferative verrucous leukoplakia to oral carcinoma: a ten years follow-up.
Navarro CM; Sposto MR; Sgavioli-Massucato EM; Onofre MA
Med Oral; 2004; 9(3):229-33. PubMed ID: 15122125
[TBL] [Abstract][Full Text] [Related]
22. [Leukoplakia and erythroplakia--two orale precursor lesions].
Grajewski S; Groneberg D
Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
[TBL] [Abstract][Full Text] [Related]
23. Diode laser: In treatment of recurrent verrucous leukoplakia.
Giri D; Agarwal N; Sinha A; Srivastava S; Mishra A
Contemp Clin Dent; 2016; 7(2):250-4. PubMed ID: 27307679
[TBL] [Abstract][Full Text] [Related]
24. Retrospective case-control study of viral pathogen screening in proliferative verrucous leukoplakia lesions.
García-López R; Moya A; Bagan JV; Pérez-Brocal V
Clin Otolaryngol; 2014 Oct; 39(5):272-80. PubMed ID: 25099922
[TBL] [Abstract][Full Text] [Related]
25. Proliferative verrucous leukoplakia and field cancerization: report of a case.
Feller L; Wood NH; Raubenheimer EJ
J Int Acad Periodontol; 2006 Apr; 8(2):67-70. PubMed ID: 16623182
[TBL] [Abstract][Full Text] [Related]
26. The importance of a proper selection area to be biopsied in nodular leukoplakia: a case report.
Pagin O; Santos PS; Del Neri NB; Gustavo de Lima H; Lara VS
Acta Stomatol Croat; 2014 Mar; 48(1):42-7. PubMed ID: 27688350
[TBL] [Abstract][Full Text] [Related]
27. Oral proliferative verrucous leukoplakia: A case report with an update.
Issrani R; Prabhu N; Keluskar V
Contemp Clin Dent; 2013 Apr; 4(2):258-62. PubMed ID: 24015023
[TBL] [Abstract][Full Text] [Related]
28. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases.
Bagan JV; Jiménez-Soriano Y; Diaz-Fernandez JM; Murillo-Cortés J; Sanchis-Bielsa JM; Poveda-Roda R; Bagan L
Oral Oncol; 2011 Aug; 47(8):732-5. PubMed ID: 21683646
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.
Gouvêa AF; Vargas PA; Coletta RD; Jorge J; Lopes MA
J Oral Pathol Med; 2010 Jul; 39(6):447-52. PubMed ID: 20412398
[TBL] [Abstract][Full Text] [Related]
30. High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia.
Gouvêa AF; Santos Silva AR; Speight PM; Hunter K; Carlos R; Vargas PA; de Almeida OP; Lopes MA
Histopathology; 2013 Mar; 62(4):551-62. PubMed ID: 23347057
[TBL] [Abstract][Full Text] [Related]
31. Oral proliferative verrucous leukoplakia: Underdiagnosed oral precursor lesion that requires retrospective clinicopathological correlation.
Mete O; Keskin Y; Hafiz G; Kayhan KB; Unur M
Dermatol Online J; 2010 May; 16(5):6. PubMed ID: 20492823
[TBL] [Abstract][Full Text] [Related]
32. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.
Kresty LA; Mallery SR; Knobloch TJ; Li J; Lloyd M; Casto BC; Weghorst CM
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760
[TBL] [Abstract][Full Text] [Related]
33. Malignant transformation of oral verrucous leukoplakia: a clinicopathologic study of 53 cases.
Liu W; Shen XM; Liu Y; Li J; Zhou ZT; Wang LZ
J Oral Pathol Med; 2011 Apr; 40(4):312-6. PubMed ID: 21342275
[TBL] [Abstract][Full Text] [Related]
34. High-Dose-Rate Brachytherapy for Primary Treatment of Refractory Proliferative Verrucous Leukoplakia of the Hard Palate.
Mohiuddin JJ; Shanti RM; Alawi F; Chang BM; Marcel J; Taunk NK; Lukens JN
Cureus; 2021 Jun; 13(6):e15696. PubMed ID: 34277283
[TBL] [Abstract][Full Text] [Related]
35. Inherited proliferative oral disorder: a reductionist approach to proliferative verrucous leukoplakia.
Radhakrishnan R
Indian J Dent Res; 2011; 22(3):365-6. PubMed ID: 22048571
[No Abstract] [Full Text] [Related]
36. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications.
Wang YP; Chen HM; Kuo RC; Yu CH; Sun A; Liu BY; Kuo YS; Chiang CP
J Oral Pathol Med; 2009 Sep; 38(8):651-6. PubMed ID: 19656267
[TBL] [Abstract][Full Text] [Related]
37. Current management strategies for verrucous hyperkeratosis and verrucous carcinoma.
Sciubba JJ; Helman JI
Oral Maxillofac Surg Clin North Am; 2013 Feb; 25(1):77-82, vi. PubMed ID: 23399397
[TBL] [Abstract][Full Text] [Related]
38. Leukoplakia: still a gallimaufry or is progress being made?--A review.
Suarez P; Batsakis JG; el-Naggar AK
Adv Anat Pathol; 1998 May; 5(3):137-55. PubMed ID: 9868520
[TBL] [Abstract][Full Text] [Related]
39. Proliferative verrucous leukoplakia: report of a case with characteristic long-term progression.
Vigliante CE; Quinn PD; Alawi F
J Oral Maxillofac Surg; 2003 May; 61(5):626-31. PubMed ID: 12730844
[No Abstract] [Full Text] [Related]
40. Proliferative verrucous leukoplakia and malignant transformation.
López-Jornet P; Alonso FC
J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1138-9. PubMed ID: 18194235
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
